NCT02967432View on ClinicalTrials.gov

Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Staphylococcus
Interventions
DRUG

Mupirocin Topical Ointment

Mupirocin ointment 1/2 inch ribbon applied topically to each nare and umbilicus twice daily for 5 days; repeat treatment courses possible.

DRUG

Petroleum Jelly

Petroleum jelly ointment 1/2 inch ribbon applied topically to each nare and umbilicus twice daily for 5 days; repeat treatment courses possible.

Trial Locations (1)

13210

Crouse Hospital - Neonatal Intensive Care Unit, Syracuse

All Listed Sponsors
collaborator

Jana Shaw, MD

UNKNOWN

collaborator

Steven Gross, MD

UNKNOWN

collaborator

David Martin, RN

UNKNOWN

collaborator

Dale Franz, RPh

UNKNOWN

collaborator

Rachel Carey

UNKNOWN

lead

Crouse Hospital

OTHER

NCT02967432 - Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU | Biotech Hunter | Biotech Hunter